SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Clark MA, Fisher C, Judson I, Thomas JM. Soft tissue sarcomas in adults. N Engl J Med. 2005; 353: 701711.
  • 2
    Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001; 19: 12381247.
  • 3
    Fahn W, Issels RD. Emerging treatments for soft tissue sarcoma of adults. Expert Opin Emerg Drugs. 2004; 9: 313334.
  • 4
    Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer. 2003; 97: 25302543.
  • 5
    Issels RD, Abdel-Rahman S, Wendtner C, et al. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft tissue sarcomas (STS) of adults: long-term results of a Phase II study. Eur J Cancer. 2001; 37: 15991608.
  • 6
    Wendtner CM, Abdel-Rahmen S, Krych M, et al. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissues sarcomas. J Clin Oncol. 2002; 21: 11351139.
  • 7
    Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in a combined treatment of cancer. Lancet Oncol. 2002; 3: 487497.
  • 8
    Hildebrandt B, Wust P, Ahlers O, et al. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol. 2002; 43: 3356.
  • 9
    Issels RD, Prenninger SW, Nagele A. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a Phase II study. J Clin Oncol. 1990; 8: 18181829.
  • 10
    Leopold KA, Dewhirst MW, Samulski TV, et al. Cumulative minutes with T90 greater than temp index is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol Biol Phys. 1993; 25: 841847.
  • 11
    Van der Zee J, Peer-Valstar JN, Rietveld PJ, de Graaf-Strukowska L, van Rhoon GC. Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys. 1998; 40: 12051212.
  • 12
    Wust P, Gellermann J, Harder C, et al. Rationale for using invasive thermometry for regional hyperthermia of pelvic tumors. Int J Radiat Oncol Biol Phys. 1998; 41: 11291137.
  • 13
    Rau B, Wust P, Tilly W, et al. Preoperative radio-chemotherapy in locally advanced recurrent rectal cancer: regional ra diofrequency hyperthermia correlates with clinical parameters. Int J Radiat Oncol Biol Phys. 2000; 48: 381391.
  • 14
    Tilly W, Gellermann J, Graf R, et al. Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0. Strahlenther Onkol. 2005; 181: 3541.
  • 15
    van Rhoon GC, Wust P. Introduction: non-invasive thermometry for thermotherapy. Int J Hyperthermia. 2005; 21: 489495.
  • 16
    Denis de Sennevielle B, Quesson B, Moonen CT. Magnetic resonance temperature imaging. Int J Hyperthermia. 2005; 21: 515531.
  • 17
    McDannold N. Quantitative MRI-based temperature mapping based on the proton resonant frequency shift: review of validation studies. Int J Hyperthermia. 2005; 21: 533546.
  • 18
    Kuroda K. Non-invasive MR thermography using the water proton chemical shift. Int J Hyperthermia. 2005; 21: 547560.
  • 19
    Gellermann J, Wlodarczyk W, Feussner A, et al. Methods and potentials of MR-tomograph to monitoring radiofrequency hyperthermia in a hybrid system. Int J Hyperthermia. 2005; 21: 497513.
  • 20
    Carter DL, MacFall JR, Clegg ST, et al. Magnetic resonance thermometry during hyperthermia for human high-grade sarcoma. Int J Radiat Oncol Biol Phys. 1998; 40: 815822.
  • 21
    Peller M, Reinl HM, Weigel A, Meininger M, Issels RD, Reiser M. T1 relaxation time at 0.2 Tesla for monitoring regional hyperthermia: feasibility study in muscle and adipose tissue. Magn Reson Med. 2002; 47: 11941201.
  • 22
    Prosnitz LR, Maguire P, Anderson JM, et al. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. Int J Radiat Oncol Biol Phys. 1999; 45: 941949.
  • 23
    Wendtner C, Abdel-Rahman S, Baumert J, et al. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a Phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. Eur J Cancer. 2001; 37: 16091616.
  • 24
    Lindner LH, Schlemmer M, Hohenberger P, et al. First interim report on the randomized EORTC 62961/ESHO-RHT 95 intergroup study (Phase III) combined with regional hyperthermia versus chemotherapy alone in the treatment of high-risk soft tissue sarcomas (HR-STS) in adults. J Clin Oncol. 2004; 23: 817. Abstract 9015.
  • 25
    Gellermann J, Wlodarczyk W, Ganter H. et al. A practical approach to perform the thermography in a hyperthermia/MR hybrid system—validation in an anthropomorphous phantom. Int J Radiat Oncol Biol Phys. 2005; 61: 267277.
  • 26
    Hildebrandt B, Rau B, Gellermann J, Wust P, Riess H. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinosis [letter to the editor]. J Clin Oncol. 2004; 22: 15271529.
  • 27
    Gellermann J, Wlodarczyk W, Hildebrandt B, et al. Non-invasive magnetic resonance thermography of recurrent rectal carcinoma in a 1.5 Tesla hybrid system. Cancer Res. 2005; 65: 19.
  • 28
    Seebass M, Beck R, Gellermann J, Nadobny J, Wust P. Electromagnetic phased arrays for regional hyperthermia—optimal frequency and antenna arrangement. Int J Hyperthermia. 2001; 17: 321336.
  • 29
    Wust P, Gellermann J, Seebass M, et al. [ Part-body hyperthermia with a radiofrequency mutliantenna applicator under online control in a 1.5 T MR-tomograph]. RoFo. 2004; 176: 363374.
  • 30
    Tilly W, Wust P, Rau B, et al. Temperature data and specific absorption rates in pelvic tumors: predictive factors and correlations. Int J Hyperthermia. 2001; 17: 172188.
  • 31
    Rau B, Wust P, Hohenberger P, et al. Preoperative hyperthermia combined with radiochemotherapy in locally advanced rectal cancer. A Phase II clinical trial. Ann Surg. 1998; 227: 380389.
  • 32
    Wust P, Stahl H, Loffel J, Seebass M, Riess H, Felix R. Clinical, physiological and anatomical determinants for radiofrequency hyperthermia. Int J Hyperthermia. 1995; 11: 151167.
  • 33
    Wust P, Nadobny J, Seebass M, et al. Influence of patient models and numerical methods on predicted power deposition patterns. Int J Hyperthermia. 1999; 15: 519540.
  • 34
    Van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial.Dutch Deep Hyperthermia Group. Lancet. 2000; 355: 11191125.
  • 35
    Juffermans JH, Hannssens PE, van Putten WL, van Rhoon GC, van der Zee J. Reirradiation and hyperthermia in rectal carcinoma: a retrospective study on palliative effect. Cancer. 2003; 98: 17591766.
  • 36
    Dewhirst MW, Sim DA. The utility of thermal dose as a predictor of tumor and normal tissue responses to combined radiation and hyperthermia. Cancer Res. 1984; 44(10 Suppl ): 4772s4780s.
  • 37
    Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005; 23: 30793085.
  • 38
    Leopold KA, Dewhirst MW, Samulski TV, et al. Cumulative minutes with T90 greater than temp index is predictive of response of superficial malignancies to hyperthermia and radiation. Int J Radiat Oncol Biol Phys. 1993; 25: 841847.
  • 39
    Wlodarczyk W, Gellermann J, Nadobny J, Wust P. Perfusion distortions and their correction in the PRF-based temperature monitoring of regional hyperthermia. Proc Intl Soc Mag Reson Med. 2005; 13: 2132. Abstract.
  • 40
    van der Zee J. Lessons learned from hyperthermia. Int J Radiat Oncol Biol Phys. 2003; 57: 596597.
  • 41
    Jones EL, Samulski TV, Dewhirst MV, et al. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma. Cancer. 2003; 98: 277282.
  • 42
    Sreenivasa G, Hildebrandt B, Kummel S, et al. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with non-resectable cervical cancer ≥ FIGO IB “bulky”. Int J Radiat Oncol Biol Phys. In press.